Evaluation of Edoxaban in Anticoagulant Naive Patients with Non-Valvular Atrial Fibrillation (NVAF) and high Creatinine Clearance
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Edoxaban (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics; Registrational
- Sponsors Daiichi Sankyo Inc
- 04 Jun 2019 This trial has been completed in Crotia (End date: 2018-10-09).
- 21 Dec 2018 Status changed from active, no longer recruiting to completed.
- 16 Dec 2018 This trial has been completed in Slovakia (End date: 2018-10-09).